Ayrapetov Marina K, Lee Sungsoo, Sun Gongqin
Department of Cell and Molecular Biology, University of Rhode Island, 117 Morrill Hall, 45 Lower College Road, Kingston, RI 02881, USA.
Protein Expr Purif. 2003 Jun;29(2):148-55. doi: 10.1016/s1046-5928(02)00698-8.
CSK family contains two protein tyrosine kinases: Csk (C-terminal Src kinase) and Chk (Csk homologous kinase). They are responsible for phosphorylating Src family protein tyrosine kinases on a C-terminal Tyr (Tyr527) and negatively regulating their activities. However, Chk and Csk have different expression patterns, mechanisms of regulation, and different biological functions, and appear to play different roles in the development of breast cancer. To obtain pure human Chk for biochemical characterization, its coding region was amplified by polymerase chain reaction and expressed as a fusion protein with glutathione S-transferase in Escherichia coli. The enzyme was highly expressed but unusually prone to proteolytic degradation during purification. Expression of the enzyme as a dual fusion protein with glutathione S-transferase on N-terminus and streptag, a 10 amino acid peptide, on C-terminus allowed purification of the full-length fusion protein. The purified enzyme was able to phosphorylate and inactivate Src. Chk (no inhibition up to 18.5 microM) and Csk (IC(50)= 1 microM) were differentially inhibited by PP2, probably due to the size difference of one residue (Thr265 in Csk versus Met304 in Chk) in the ATP-binding domain. The expression, purification, and initial characterizations of Chk provided an important step toward full characterization of Chk and Csk, two important enzymes in cellular regulation.
CSK家族包含两种蛋白酪氨酸激酶:Csk(C末端Src激酶)和Chk(Csk同源激酶)。它们负责使Src家族蛋白酪氨酸激酶的C末端酪氨酸(Tyr527)磷酸化,并对其活性进行负调控。然而,Chk和Csk具有不同的表达模式、调控机制和不同的生物学功能,并且在乳腺癌的发展中似乎发挥着不同的作用。为了获得用于生化特性分析的纯人Chk,通过聚合酶链反应扩增其编码区,并在大肠杆菌中作为与谷胱甘肽S-转移酶的融合蛋白进行表达。该酶高度表达,但在纯化过程中异常容易发生蛋白水解降解。将该酶作为N末端带有谷胱甘肽S-转移酶和C末端带有10个氨基酸肽链标签(streptag)的双融合蛋白进行表达,使得全长融合蛋白得以纯化。纯化后的酶能够使Src磷酸化并使其失活。PP2对Chk(高达18.5微摩尔时无抑制作用)和Csk(IC50 = 1微摩尔)的抑制作用存在差异,这可能是由于ATP结合结构域中一个残基的大小差异(Csk中的Thr265与Chk中的Met304)所致。Chk的表达、纯化及初步特性分析为全面表征Chk和Csk这两种细胞调控中的重要酶迈出了重要一步。